Analyst Recommendations

Help
Analyst
Ticker
Result
Analyst Action
AI Recommendation
Period
Limit
Return %
Filters
Performance Current: Return 14.60% Success Rate 65.0%
Total: 11190 • Pg: 68/560 ← Back Next →
CRVS Corvus Pharmaceuticals
2025-10-13 Barclays
Δh% 71.86%
Update Sell
Price Then 6.93
Price h 11.91
Target 16
ATAI Atai Life Sciences
2025-10-13 Needham
Δh% -20.39%
Update Sell
Price Then 5.1
Price h 4.06
Target 12
DFTX Definium Therapeutics
2025-10-13 Needham
Δh% 107.28%
Update Hold
Price Then 11.81
Price h 24.48
Target 28
AES AES Corporation
2025-10-13 Susquehanna
Δh% 3.91%
Target Raised Hold
Price Then 14.07
Price h 14.62
Target 17
BN Danone
2025-10-13 Morgan Stanley
Δh% 0.54%
Target Raised Hold
Price Then 44.2
Price h 44.44
Target 54
AREC American Resources Corp
2025-10-13 Roth Capital
Δh% -47.3%
Target Raised Sell
Price Then 4.08
Price h 2.15
Target 5
AVY Avery Dennison
2025-10-13 Truist Financial
Δh% 0.01%
Target Lowered Hold
Price Then 158.67
Price h 158.68
Target 203
WY Weyerhaeuser
2025-10-13 Truist Financial
Δh% 1.61%
Target Lowered Buy
Price Then 23.935
Price h 24.32
Target 27
CYBR CyberArk Software
2025-10-14 Barclays
Δh% -18.88%
Rating Downgraded Sell
Price Then 504.02
Price h 408.85001
Target 520
BILI Bilibili
2025-10-14 Macquarie
Δh% -36.86%
Update Sell
Price Then 27.24
Price h 17.2
Target 36.03
FAST Fastenal
2025-10-14 Barclays
Δh% 8.41%
Target Lowered Buy
Price Then 42.33
Price h 45.89
Target 45
LB L Brands
2025-10-14 Barclays
Δh% 23.46%
Target Lowered Sell
Price Then 51.8
Price h 63.95
Target 57
IMVT Immunovant
2025-10-14 Truist Financial
Δh% 103.69%
Update Hold
Price Then 17.35
Price h 35.34
Target 16
AHR American Healthcare REIT
2025-10-14 KeyBanc
Δh% 12.67%
Target Raised Hold
Price Then 41.29
Price h 46.52
Target 43
IBKR Interactive Brokers
2025-10-14 Piper Sandler
Δh% 36.13%
Target Raised Buy
Price Then 70.52
Price h 96
Target 80
NVO Novo Nordisk
2025-10-14 BMO Capital
Δh% -24.89%
Target Raised Hold
Price Then 57.5
Price h 43.19
Target 55
IMAX IMAX
2025-10-14 Roth Capital
Δh% 39.89%
Target Raised Buy
Price Then 31.69
Price h 44.33
Target 40
MKTX MarketAxess
2025-10-14 Loop Capital Markets
Δh% -30.4%
Target Lowered Sell
Price Then 172.9
Price h 120.33
Target 164
ARCC Ares Capital
2025-10-14 UBS
Δh% -7.23%
Target Lowered Sell
Price Then 19.435
Price h 18.03
Target 21
DVA DaVita
2025-10-14 Truist Financial
Δh% 68.54%
Target Lowered Buy
Price Then 123.36
Price h 207.91
Target 140
Date Analyst Stock Action AI at Time Price Then Price h Δh% Target Portfolio
2025-10-13 Barclays
CRVS Corvus Pharmaceuticals
Update Sell 6.93 11.91 71.86% 16
2025-10-13 Needham
ATAI Atai Life Sciences
Update Sell 5.1 4.06 -20.39% 12
2025-10-13 Needham
DFTX Definium Therapeutics
Update Hold 11.81 24.48 107.28% 28
2025-10-13 Susquehanna
AES AES Corporation
Target Raised Hold 14.07 14.62 3.91% 17
2025-10-13 Morgan Stanley
BN Danone
Target Raised Hold 44.2 44.44 0.54% 54
2025-10-13 Roth Capital
AREC American Resources Corp
Target Raised Sell 4.08 2.15 -47.3% 5
2025-10-13 Truist Financial
AVY Avery Dennison
Target Lowered Hold 158.67 158.68 0.01% 203
2025-10-13 Truist Financial
WY Weyerhaeuser
Target Lowered Buy 23.935 24.32 1.61% 27
2025-10-14 Barclays
CYBR CyberArk Software
Rating Downgraded Sell 504.02 408.85001 -18.88% 520
2025-10-14 Macquarie
BILI Bilibili
Update Sell 27.24 17.2 -36.86% 36.03
2025-10-14 Barclays
FAST Fastenal
Target Lowered Buy 42.33 45.89 8.41% 45
2025-10-14 Barclays
LB L Brands
Target Lowered Sell 51.8 63.95 23.46% 57
2025-10-14 Truist Financial
IMVT Immunovant
Update Hold 17.35 35.34 103.69% 16
2025-10-14 KeyBanc
AHR American Healthcare REIT
Target Raised Hold 41.29 46.52 12.67% 43
2025-10-14 Piper Sandler
IBKR Interactive Brokers
Target Raised Buy 70.52 96 36.13% 80
2025-10-14 BMO Capital
NVO Novo Nordisk
Target Raised Hold 57.5 43.19 -24.89% 55
2025-10-14 Roth Capital
IMAX IMAX
Target Raised Buy 31.69 44.33 39.89% 40
2025-10-14 Loop Capital Markets
MKTX MarketAxess
Target Lowered Sell 172.9 120.33 -30.4% 164
2025-10-14 UBS
ARCC Ares Capital
Target Lowered Sell 19.435 18.03 -7.23% 21
2025-10-14 Truist Financial
DVA DaVita
Target Lowered Buy 123.36 207.91 68.54% 140